Indian News


pharma-022018_23jan19.jpg Today's Daily Dose brings you news about Green Growth's unsolicited take-over bid for Aphria; the stock offering of Bellerophon, PTC Therapeutics; Accuray's better-than-expected Q2 results; UNITY Biotechnology's progress in osteoarthritis trial; positive data from Ultragenyx Pharma's phase II study of UX007 in patients with long-chain fatty acid oxidation disorder.

pharmadown-jan22.jpg The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

pharmaup-jan22.jpg The following are some of today's top gainers in the pharma/biotech sector.

avro-jan22.jpg Shares of AVROBIO Inc. (AVRO) have lost 39% of their value over the last 1 month in sharp contrast to the iShares Nasdaq Biotechnology ETF (IBB) index which has gained 8% during the same period.

cancer-011819.jpg Cancer is the second leading cause of death in the world, next to heart disease. Let's take a look at some of the companies whose cancer drugs are in phase III /pivotal trials.

Follow RTT